IMMUNIC, INC. — Form D

IMMUNIC, INC. of NEW YORK, X1, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-04. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (56)

Showing 25 of 56 people.

NameRoleLocation
THORVALD NAGELDirectorNew York, NY
JOERG NEERMANDirectorNew York, NY
SIMONA SKERJANECDirectorNEW YORK, NY
JASON TARDIOExecutive OfficerNew York, NY
Muneer A SatterDirectorChicago, IL
Patrick WalshExecutive OfficerNew York, NY
Andreas MuehlerExecutive OfficerNew York, NY
Barclay PhillipsDirectorNew York, NY
Inderpal SinghExecutive OfficerNew York, NY
Daniel VittDirectorNew York, NY
Daniel VittExecutive OfficerNew York, NY
Duane NashDirectorNew York, NY
Tamar HowsonDirectorNew York, NY
Jorg NeermannDirectorNew York, NY
Richard RudickDirectorNew York, NY
Glenn WhaleyExecutive OfficerNew York, NY
Maria TornsenDirectorNew York, NY
Hella KohlhofExecutive OfficerNew York, NY
Vincent OssipowDirectorNew York, NY
Monika Maria TornsenDirectorNew York, NY
Jorg NeermanDirectorNew York, NY
Inderpal Maria SinghExecutive OfficerNew York, NY
Glenn Maria WhaleyExecutive OfficerNew York, NY
Errol R HalperinDirectorChicago, IL
CHARLES LIAMOSDirectorHAYWARD, CA

Other filings by this issuer (23)

Showing 15 of 23 filings.

FiledFormOfferingSold
2024-01-19D$240.0M$80.0M
2022-10-18D$60.0M$60.0M
2014-03-07D/A$13.9M$13.9M
2014-02-04D$12.0M$12.0M
2014-01-31D/A$32.0M$32.0M
2013-06-24D/A$22.5M$22.5M
2013-03-14D$14.3M$14.3M
2012-11-07D/A$86.1M$86.1M
2012-10-09D$76.1M$76.1M
2012-06-22D$2.5M
2012-02-17D$1.5M$930K
2011-06-23D$56.9M$22.6M
2011-06-22D/A$16.3M$16.3M
2011-02-07D/A$14.0M
2011-01-04D/A$13.4M

More